✦ LIBER ✦

A comeback for anti-CD3s in type 1 diabetes?

Book ID: 121011858
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 99 KB
Volume: 12
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd4120

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-CD3 mAbs for treatment of type 1 di

Anti-CD3 mAbs for treatment of type 1 diabetes

✍ Adam Kaufman; Kevan C. Herold 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract The use of anti‐CD3 monoclonal antibodies (mAbs) has moved from the bench to the bedside. The experience with the anti‐human CD3 mAb OKT3 for treatment of transplant rejection identified limitations that were largely overcome with the creation of humanized non‐FcR binding antibodies: Te

Anti-CD3 antibodies for type 1 diabetes:

Anti-CD3 antibodies for type 1 diabetes: beyond expectations

✍ Jean-François Bach 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 256 KB

Anti-CD3 clinical trials in type 1 diabe

Anti-CD3 clinical trials in type 1 diabetes mellitus

✍ Daifotis, Anastasia G.; Koenig, Scott; Chatenoud, Lucienne; Herold, Kevan C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Anti-CD3 Monoclonal Antibody in New-Onse

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

✍ Herold, Kevan C.; Hagopian, William; Auger, Julie A.; Poumian-Ruiz, Ena; Taylor, 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 110 KB

Treatment of Type 1 Diabetes with Anti-C

Treatment of Type 1 Diabetes with Anti-CD3 Monoclonal Antibody

✍ Mariela Glandt; William Hagopian; Kevan C. Herold 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 101 KB

Treatment of type 1 diabetes with anti-C

Treatment of type 1 diabetes with anti-CD3 monoclonal antibody

✍ Kaven C. Herold; Lesley Taylor 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 113 KB